2.4 mg semaglutide Wegovy (Semaglutide) Weight Loss Injector mg/0.75 mL, 4 Pens Per Box **Refrigerated** Wegovy is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight Semaglutide may reduce Alzheimer's risk

And many experience uncomfortable side effectsnausea, serious fatigue, or not being able to keep food down

Major medical associations, including the American Diabetes Association and European Association, now recommend GLP-1 receptor agonists like Semaglutide early in treatment algorithms, with healthcare systems finding improved patient outcomes and reduced long-term complications

American Journal of Physiology-Endocrinology and Metabolism, 2016, 310(11): E947-E957

While RYBELSUS is an oral version of semaglutide approved to improve glycemic control in adults with type 2 diabetes mellitus, it requires daily administration at a significantly higher dose than the subcutaneous equivalent

Hoshida, T

2021 Jan 28;13(2):421